Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
The Pendulum Swings Between Zero Tolerance and Harm Reduction
A panel of addiction experts explores changing attitudes toward the harm reduction approach to substance use disorder.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
The Movement Away From Abstinence and Toward Addiction Resistance
The unrealistic focus of substance abuse education on abstinence is yielding to a more enlightened approach based on addiction resistance.
Continuation, the Third C of Addiction
How is substance dependence defined? And is long-term, continuous recovery from food addiction possible?
California Lawmakers Move to Unlock Research on Psychedelics and Addiction Treatment
California lawmakers push to dismantle a bureaucratic bottleneck that has stymied progress in studying addiction treatment and psychedelics.